Bilateral reduction mammoplasty following breast cancer: A case-control study (part 9)

17 Aug

Although the incidence of breast cancer has stabilized in Canada within the past five years, there has been an associated 25% decrease in mortality, with five-year survival rates for patients living with breast cancer expected to be up to 80%. While the true incidence of breast hypertrophy is not known, one can surmise that a subpopulation of breast cancer patients are living with significant symptoms due to macromastia or breast hypertrophy. On completion of their breast cancer treatments, many seek surgical consultation for breast reduction mammoplasty to contend with the resultant breast asymmetry and continued symptoms of breast hypertrophy.
We acknowledge that there were limitations to our study. We had a very small sample size and, therefore, no statistical analyses could be performed. The present study was also retrospective in nature, which can result in incorrect or incomplete data. However, our findings give better insight to patients of the potential risks of reduction mammo-plasty. A summary of the nature and rate of complications on the radiated breast is provided by the present analysis. It has also led to the proposal of a new surgical principle stating that due to greater contracture post-treatment of the radiated breast tissue, one should avoid the tendency to under-reduce the control breast by perhaps resecting 200 g more than anticipated.


The results of the present retrospective, match case-control study, although having a small sample size, suggest that women with a history of breast cancer treated by lumpectomy and radiation can successfully undergo reduction mammoplasty surgery for the treatment of breast hypertrophy and its related physical and psychological symptoms. A high occurrence of postoperative complications on the radiated breast following bilateral breast reduction was observed, and the risk of complications of delayed wound healing, infection and scarring were increased four- to 10-fold. However, physicians should inform the patient that the primary purpose of the bilateral reduction mammo-plasty procedure is to reduce the adverse symptoms caused by their macromastia. The physician should emphasize that while the procedure will be successful in achieving this goal, the irradiated breast may have a suboptimal cosmetic result and that complications may arise. Therefore, after proper patient counselling that results in realistic expectations, the patient can undergo a successful reduction mammo-plasty to relieve the symptoms of her breast hypertrophy. Thorough follow-up of wound healing and mammographic surveillance six months following surgery is imperative. Find most trusted pharmacy that will give you vardenafil online pharmacy in the amounts required without any need for a prescription. You will see that shopping with a place you can already trust over and over again is very affordable and always nice.